![]() Urgency, incontinence, and urinary frequency can be caused by urinary tract infections or kidney stones-or, in men, a prostate infection or prostate enlargement. So start by working with a general practitioner, who can determine whether there may be an underlying cause for your symptoms. But the symptoms can almost always be eased, Hochman says. “People often don’t bring up issues of incontinence with their clinical providers, either due to embarrassment or because they feel there are no available options that can help-or that surgery may be the only option,” says Tomas Griebling, M.D., professor of urology and senior associate dean for medical education at the University of Kansas School of Medicine. What should you do if you’re experiencing bladder problems? First, speak up. So when should you consider these meds? And are there other effective ways to ease bladder problems? Consider this expert advice. Oxybutynin is also sold over the counter in patch form as Oxytrol for Women. (All are anticholinergics, except for mirabegron.) ![]() Seven prescription drugs are available to treat urge incontinence: darifenacin (Enablex), fesoterodine (Toviaz), mirabegron (Myrbetriq), oxybutynin (Ditropan XL pills, Gelnique topical gel, and generic), solifenacin (Vesicare), tolterodine (Detrol, Detrol LA, and generic), and trospium (generic only). More than half of people with what’s been dubbed “overactive bladder” stop taking medication within six months, often because of side effects such as dry mouth, blurry vision, constipation, and dizziness. “However, this study does raise concerns, and anticholinergic medications for incontinence have several other well-established side effects,” Hochman says. ![]() The research doesn’t prove that the drugs cause dementia-only that there is an association between the two. “But this study suggests that the effects may not entirely reverse after stopping the medication.” Only accredited investors, as defined under applicable securities laws, will be allowed to purchase the Company’s common membership units, which for natural persons, are investors who meet certain minimum annual income or net worth thresholds or other requirements.“While this class of medications has long been known to be linked to memory troubles, it was not known whether the effects were permanent,” says Michael Hochman, M.D., an associate professor of clinical medicine at the Keck School of Medicine at the University of Southern California. Investors should not assume they will be able to resell the Company’s common membership units and investors must be able to bear the risk of loss of their entire investment. The Company’s common membership units offered by the Company’s private placement memorandum are restricted securities subject to specific restrictions on transferability and resale, are highly illiquid and are subject to significant risk. Securities and Exchange Commission nor any other regulatory authority has passed upon the merits of, or given its approval to, the Company’s common membership units, the terms of the Company’s private placement, or the accuracy or completeness of the Company’s private placement memorandum or any offering materials. As a result, the Company’s private placement memorandum is not required to comply with specific disclosure requirements that apply to registration under the Securities Act. The Company’s membership units have not been and will not be registered under the Securities Act of 1933, as amended, or applicable state securities laws nor the securities laws of any other jurisdiction, in each case in reliance upon exemptions from such registration provided by the Securities Act of 1933, as amended, and Regulation D Rule 506(c) and the comparable exemptions from registration provided by other applicable securities laws. Such an offer or solicitation of an offer can only be made through the Company’s private placement memorandum. ![]() The statements above are for informational purposes only and do not constitute an “offer” or a “solicitation of an offer” to sell securities. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |